489 related articles for article (PubMed ID: 22120137)
21. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
[TBL] [Abstract][Full Text] [Related]
22. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
[TBL] [Abstract][Full Text] [Related]
23. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
24. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
25. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
Keitel V; Vogt C; Häussinger D; Kubitz R
Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
[TBL] [Abstract][Full Text] [Related]
26. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
[TBL] [Abstract][Full Text] [Related]
27. The bile salt export pump (BSEP) in health and disease.
Kubitz R; Dröge C; Stindt J; Weissenberger K; Häussinger D
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):536-53. PubMed ID: 22795478
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
[TBL] [Abstract][Full Text] [Related]
29. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
[TBL] [Abstract][Full Text] [Related]
30. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
[TBL] [Abstract][Full Text] [Related]
31. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.
Telbisz Á; Homolya L
Expert Opin Ther Targets; 2016; 20(4):501-14. PubMed ID: 26573700
[TBL] [Abstract][Full Text] [Related]
33. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
Strautnieks SS; Bull LN; Knisely AS; Kocoshis SA; Dahl N; Arnell H; Sokal E; Dahan K; Childs S; Ling V; Tanner MS; Kagalwalla AF; Németh A; Pawlowska J; Baker A; Mieli-Vergani G; Freimer NB; Gardiner RM; Thompson RJ
Nat Genet; 1998 Nov; 20(3):233-8. PubMed ID: 9806540
[TBL] [Abstract][Full Text] [Related]
34. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
35. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
36. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
Vallejo M; Briz O; Serrano MA; Monte MJ; Marin JJ
J Hepatol; 2006 Jun; 44(6):1150-7. PubMed ID: 16458994
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
38. Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference.
Kenna JG
Curr Protoc Toxicol; 2014 Aug; 61():23.7.1-15. PubMed ID: 25104267
[TBL] [Abstract][Full Text] [Related]
39. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
de Lima Toccafondo Vieira M; Tagliati CA
Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
[TBL] [Abstract][Full Text] [Related]
40. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
